BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33519467)

  • 1. 3-Hydroxyphthalic Anhydride-Modified Chicken Ovalbumin as a Potential Candidate Inhibits SARS-CoV-2 Infection by Disrupting the Interaction of Spike Protein With Host ACE2 Receptor.
    Liang T; Qiu J; Niu X; Ma Q; Zhou C; Chen P; Zhang Q; Chen M; Yang Z; Liu S; Li L
    Front Pharmacol; 2020; 11():603830. PubMed ID: 33519467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broad and Differential Animal Angiotensin-Converting Enzyme 2 Receptor Usage by SARS-CoV-2.
    Zhao X; Chen D; Szabla R; Zheng M; Li G; Du P; Zheng S; Li X; Song C; Li R; Guo JT; Junop M; Zeng H; Lin H
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32661139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scaffold morphing of arbidol (umifenovir) in search of multi-targeting therapy halting the interaction of SARS-CoV-2 with ACE2 and other proteases involved in COVID-19.
    Choudhary S; Silakari O
    Virus Res; 2020 Nov; 289():198146. PubMed ID: 32866534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.
    Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S
    J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational Alanine Scanning and Structural Analysis of the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Complex.
    Laurini E; Marson D; Aulic S; Fermeglia M; Pricl S
    ACS Nano; 2020 Sep; 14(9):11821-11830. PubMed ID: 32833435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of SARS-CoV-2 Cell Entry Inhibitors by Drug Repurposing Using
    Choudhary S; Malik YS; Tomar S
    Front Immunol; 2020; 11():1664. PubMed ID: 32754161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combinations of 3-hydroxyphthalic anhydride-modified ovalbumin with antiretroviral drug-based microbicide candidates display synergistic and complementary effects against HIV-1 infection.
    Li L; Tan S; Lu H; Lu L; Yang J; Jin H; Liu S; Jiang S
    J Acquir Immune Defic Syndr; 2011 Apr; 56(5):384-92. PubMed ID: 21239999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antiviral activity of 3-hydroxyphthalic anhydride-modified ovalbumin against herpes simplex virus 2 in vitro].
    He LL; Duan JM; Qiu JY; Yu F; Liu SW; Li L
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jun; 31(7):1175-8. PubMed ID: 21764688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coevolution, Dynamics and Allostery Conspire in Shaping Cooperative Binding and Signal Transmission of the SARS-CoV-2 Spike Protein with Human Angiotensin-Converting Enzyme 2.
    Verkhivker G
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33158276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ambroxol Hydrochloride Inhibits the Interaction between Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein's Receptor Binding Domain and Recombinant Human ACE2.
    Olaleye OA; Kaur M; Onyenaka CC
    bioRxiv; 2020 Sep; ():. PubMed ID: 32995775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 pandemic: Insights into structure, function, and hACE2 receptor recognition by SARS-CoV-2.
    Mittal A; Manjunath K; Ranjan RK; Kaushik S; Kumar S; Verma V
    PLoS Pathog; 2020 Aug; 16(8):e1008762. PubMed ID: 32822426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-Specific
    Hashizume M; Gonzalez G; Ono C; Takashima A; Iwasaki M
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33418950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the genetic variation in ACE2 on the structural recognition by the novel coronavirus (SARS-CoV-2).
    Guo X; Chen Z; Xia Y; Lin W; Li H
    J Transl Med; 2020 Aug; 18(1):321. PubMed ID: 32831104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elucidating Interactions Between SARS-CoV-2 Trimeric Spike Protein and ACE2 Using Homology Modeling and Molecular Dynamics Simulations.
    Sakkiah S; Guo W; Pan B; Ji Z; Yavas G; Azevedo M; Hawes J; Patterson TA; Hong H
    Front Chem; 2020; 8():622632. PubMed ID: 33469527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A molecular docking study revealed that synthetic peptides induced conformational changes in the structure of SARS-CoV-2 spike glycoprotein, disrupting the interaction with human ACE2 receptor.
    Souza PFN; Lopes FES; Amaral JL; Freitas CDT; Oliveira JTA
    Int J Biol Macromol; 2020 Dec; 164():66-76. PubMed ID: 32693122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites.
    Qiao B; Olvera de la Cruz M
    ACS Nano; 2020 Aug; 14(8):10616-10623. PubMed ID: 32806067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells.
    Wang K; Chen W; Zhang Z; Deng Y; Lian JQ; Du P; Wei D; Zhang Y; Sun XX; Gong L; Yang X; He L; Zhang L; Yang Z; Geng JJ; Chen R; Zhang H; Wang B; Zhu YM; Nan G; Jiang JL; Li L; Wu J; Lin P; Huang W; Xie L; Zheng ZH; Zhang K; Miao JL; Cui HY; Huang M; Zhang J; Fu L; Yang XM; Zhao Z; Sun S; Gu H; Wang Z; Wang CF; Lu Y; Liu YY; Wang QY; Bian H; Zhu P; Chen ZN
    Signal Transduct Target Ther; 2020 Dec; 5(1):283. PubMed ID: 33277466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a Potential Peptide Inhibitor of SARS-CoV-2 Targeting its Entry into the Host Cells.
    Baig MS; Alagumuthu M; Rajpoot S; Saqib U
    Drugs R D; 2020 Sep; 20(3):161-169. PubMed ID: 32592145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System.
    Costa LB; Perez LG; Palmeira VA; Macedo E Cordeiro T; Ribeiro VT; Lanza K; Simões E Silva AC
    Front Cell Dev Biol; 2020; 8():559841. PubMed ID: 33042994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity.
    Zhu Y; Yu D; Yan H; Chong H; He Y
    J Virol; 2020 Jul; 94(14):. PubMed ID: 32376627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.